Delphinus Medical Technologies, Inc. — Form D/A

Delphinus Medical Technologies, Inc. of NOVI, MI, a company, filed a Form D amendment with the SEC on 2025-04-03. The offering totals $27.6M, of which $27.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Hugo BraunDirectorNOVI, MI
Rachel BremDirectorNOVI, MI
Mark ForchetteDirectorNOVI, MI
Michael FultonDirectorNOVI, MI
Michael GrossDirectorAnn Arbor, MI
Ronald HoDirectorNOVI, MI
John NeisDirectorNOVI, MI
Scott WhiteDirectorChampaign, IL
Elise BermanExecutive OfficerNOVI, MI
Scott WhiteExecutive OfficerChampaign, IL
Mark ForchetteExecutive OfficerNOVI, MI
Michael EmeryExecutive OfficerNOVI, MI
Paul McCreadieDirectorANN ARBOR, MI
Heather RoneExecutive OfficerNOVI, MI
Olivier RoyExecutive OfficerNOVI, MI
Neb DuricExecutive OfficerNOVI, MI
Shawn O'BrienExecutive OfficerNOVI, MI
John J NeisDirectorSarasota, FL
Paul J McCreadieDirectorMenlo Park, CA
Michael J FultonDirectorSt. Louis Park, MN
Debra SaundersExecutive OfficerNovi, MI
Francis DobschaExecutive OfficerNovi, MI
Michael J GrossDirectorPlymouth, MI
Hugo J BraunDirectorPlymouth, MI
Chris J SandersExecutive OfficerPlymouth, MI

Other filings by this issuer (8)

FiledFormOfferingSold
2024-11-26D/A$20.4M$20.4M
2024-04-05D$15.0M$5.3M
2023-06-30D$8.0M$5.0M
2022-09-13D$30.4M$30.4M
2017-04-20D$25.0M$8.2M
2015-09-11D$45.0M$39.5M
2010-10-12D/A$9.6M$7.2M
2010-05-21D$8.0M$6.0M

More